Geographic Disparities Affect Access to Buprenorphine Services for Opioid Use Disorder

Access to buprenorphine services remains challenging in many localities, despite substantial increases in the number of waivered providers and the total patient capacity nationwide. Specifically, among the 1,000-plus counties in the United States that OIG identified as being at the greatest risk from the opioid crisis, more than half did not have adequate capacity to treat patients in need with buprenorphine in office-based settings. Read More.